Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in CHF Patients Undergoing Abdominal Cancer Surgery
NCT03557255Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosimendan in heart failure (HF), sponsored by National Cancer Institute. Started Aug 2017; status: completed.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03557255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557255.